Fig. 1From: Aberrant hydroxymethylation in promoter CpG regions of genes related to the cell cycle and apoptosis characterizes advanced chronic myeloid leukemia disease, poor imatinib respondents and poor survivalFrequency of CpG dinucleotide hydroxymethylation of different genes among CML patients in different clinical stages of the diseaseBack to article page